Trimetazidin Retard Teva

Trimetazidine Dihydrochloride Retard Teva is a sustained-release oral medication used to support heart function. It helps maintain cellular energy in cardiac tissues during oxygen deficiency. This EU-sourced option is designed for long-term cardiovascular support. Ideal for those seeking extended-release heart health support.

Trimetazidine Dihydrochloride Retard Teva is primarily used to help manage angina pectoris, a condition marked by chest pain due to reduced blood flow to the heart. It supports heart muscle function by optimizing energy metabolism in cells, particularly during periods of oxygen shortage. This medication is often prescribed as part of a broader cardiovascular care plan.

Users may experience improved exercise tolerance and reduced frequency of angina attacks when taking Trimetazidine Dihydrochloride Retard Teva. Some individuals report feeling more comfortable during physical activities that previously caused discomfort. The sustained-release formulation aims to provide steady support throughout the day.

Store Trimetazidine Dihydrochloride Retard Teva in a cool, dry place away from direct sunlight. Keep the medication out of reach of children and pets. If you experience persistent dizziness or unusual fatigue, consult a healthcare professional. Always follow the storage instructions provided with the product.

Trimetazidine Dihydrochloride Retard Teva may interact with other medications metabolized by the liver, such as certain antidepressants or antifungals. Alcohol consumption may enhance drowsiness or dizziness. Inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.